Orthofix Medical Inc.OFIXNASDAQ
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank86
3Y CAGR+44.5%
5Y CAGR+2.7%
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

3Y CAGR
+44.5%/yr
vs -22.0%/yr prior
5Y CAGR
+2.7%/yr
Recent acceleration
Acceleration
+66.4pp
Accelerating
Percentile
P86
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM10.24%+339.6%
2024-4.28%+59.8%
2023-10.65%-413.3%
20223.40%-26.4%
20214.62%-48.4%
20208.95%+2556.1%
20190.34%-96.3%
20189.17%-34.7%
201714.05%+44.4%
20169.73%-